Oliver Fetzer

Oliver Fetzer

Director/Board Member at TECAN GROUP AG

Net worth: 670 248 $ as of 2026-05-30

62 year
Health Technology
Consumer Services
Commercial Services

Profile

Oliver Steffen Fetzer currently works at Viridos, Inc., as Chief Executive Officer & Director from 2014 and Tecan Group AG, as Non-Executive Director from 2011.
Dr. Fetzer also formerly worked at Cerulean Pharma, Inc., as President, Chief Executive Officer & Director from 2009 to 2014, Arena Pharmaceuticals, Inc., as Independent Director from 2017 to 2022, Auxilium Pharmaceuticals LLC, as Independent Director from 2005 to 2015, The Boston Consulting Group, Inc., as Managing Director & Partner from 2000 to 2002, Cubist Pharmaceuticals LLC, as Senior Vice President-Research & Development from 2002 to 2007, and Bayer AG, as Principal.
Dr. Fetzer received his Masters Business Admin degree from Carnegie Mellon University, doctorate degree from The Medical University of South Carolina, and undergraduate degree from College of Charleston.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-12-30 3,370 ( 0.03% ) 670 248 $ 2026-05-30

Oliver Fetzer active positions

CompaniesPositionStart
TECAN GROUP AG Director/Board Member 2011-04-18
Chief Executive Officer 2014-10-26

Former positions of Oliver Fetzer

CompaniesPositionEnd
ARENA PHARMACEUTICALS Director/Board Member 2022-03-10
AUXILIUM PHARMACEUTICALS, INC. Director/Board Member 2015-01-28
Chief Executive Officer 2014-10-28
CUBIST PHARMACEUTICALS INC Chief Tech/Sci/R&D Officer 2006-12-31
Corporate Officer/Principal 2001-12-31
See the detail of Oliver Fetzer's experience

Training of Oliver Fetzer

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

77

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Consumer Services

Consumer Services

Health Technology